Best Phage Therapy Podcasts (2024)

1
PERSONALIZED MEDICINE WITH PHAGE THERAPY TO TARGET PATIENTS AND BACTERIA 27:25

10d ago27:25

27:25

In this Part 2 of the Alloutcoach podcast episode focused on phage therapy to fight infections and antimicrobial resistance, I spoke to the Chief Physician at the globally leading center of excellence of an alternative, effective treatment approach to antibiotics, Dr. Dea Nizharadze at the Eliava Phage Therapy Center (EPTC) based in Tbilisi, Georgi…

1
Communicable E4 - The BLING-3 trial & continuous beta-lactam infusion: should these results change your practice? 44:52

3d ago44:52

44:52

Hosts Angela Huttner & Erin McCreary welcome Prof. David Paterson (Singapore) and Prof. Josh Davis (Newcastle, Australia) to discuss the design and results of the BLING-3 trial, which compared continuous infusion of beta-lactam antibiotics to standard intermittent dosing in 7000 critically ill patients across 104 intensive-care units. In unadjusted…

1
Turning the Output of the Microbiology Laboratory Into Gold 42:07

5d ago42:07

42:07

The European alchemists of the 12th century sought to find the philosopher’s stone, a substance that would transmute base metals, such as lead, into precious metals, such as silver and gold. Today, we discuss whether data analysis, including machine learning, can transmute base laboratory data into precious clinical tools. We will use antimicrobial…

1
Communicable E3 - The new WHO Priority Pathogens List: which bugs to target first? 42:58

17d ago42:58

42:58

What are WHO's most wanted bacterial pathogens in 2024? Hosts Angela Huttner & Oana Sandulescu welcome guests Dr. Hatim Sati of the World Health Organisation (WHO) and Dr. Erin Duffy (CARB-X) to discuss WHO’s new Priority Pathogens List. Developed by WHO and a panel of global experts, the List identifies the ‘top’ bacteria for which research & deve…

1
REVIVING PHAGE DISCOVERY TO FIGHT INFECTIONS AND ANTIMICROBIAL RESISTANCE 19:19

18d ago19:19

19:19

In this special episode I spoke with an international guest from my native country, Republic of Georgia, and global ambassador of a critical alternative solution against tough chronic infections and antimicrobial resistance on behalf of a global center of excellence in bacteriophage therapy, discovered over 100 years ago. My guest, Davit Sturua, Do…

1
Communicable E2 - Phage therapy: does it work and will we have access? 54:00

1M ago54:00

54:00

In this episode, hosts Josh Davis (Newcastle, Australia) and Angela Huttner (Geneva, Switzerland) interview the phage ‘microbiologist-clinician duo’, Drs. Shawna McCallin and Lorenz Leitner (Balgrist Hospital, Zurich, Switzerland). They explore the history of phages, the process of bringing phage therapy to a patient, potential resistance to phages…

1
Training in Antimicrobial Resistance: Gaps and Opportunities 40:31

1M ago40:31

40:31

Antimicrobial resistance is a priority public health problem with complex roots and connotations. However, due to a lack of focus on this topic, research training programs, specifically those focused on AMR are limited. Additionally, scientific meetings that particularly highlight the science of antimicrobial resistance are scarce. We recently publ…

1
Edwin Armitage, Saffiatou Darboe, and Lamin Jaiteh on Streptococcus pyogenes 26:25

1M ago26:25

26:25

Elena Dalla Vecchia of The Lancet Microbe speaks to Edwin Armitage, Saffiatou Darboe, and Lamin Jaiteh about Streptococcus pyogenes carriage and transmission in households in The Gambia. Read the full article: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(24)00046-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanmic Continue thi…

1
HEALTH EMERGENCY DESPITE ADVANCES IN TREATMENTS FOR OBESITY 42:14

2M ago42:14

42:14

Patients with obesity are at the forefront of latest developments in medicine once again, with new options but many new questions still to be solved, including a public health emergency and shortage despite the latest advances. In this latest interview Angela Fitch MD, FACP, FOMA, Dipl. ABOM critically reviews the advances, public health emergency,…

1
Late-breaker clinical trial results from ESCMID Global 2024: Should they change your practice? 58:02

2M ago58:02

58:02

CMI Communications editors Angela Huttner, Marc Bonten, and Erin McCreary discuss late-breaker clinical trials presented at ESCMID Global (ECCMID) in Barcelona, providing insights into the trials’ designs, results, and implications. The DOTS trial compared two doses of long-acting dalbavancin to standard of care in patients with complicated S. aure…

1
10 Years of Rhodococcus: Clinical Trends and Susceptibility Profiles 37:38

3M ago37:38

37:38

Rhodococcus infections are uncommon, however they can cause serious disease in certain patients. There are a number of challenges though when dealing with Rhodococcus infections, including the fact that much of what we know around their susceptibility profiles and the clinical management of infected individuals actually comes from a number case ser…

1
RESOLVING ROOT CAUSES OF CHRONIC DISEASE WITH DIGITAL INNOVATION 31:13

3M ago31:13

31:13

If you have an interest in digital health or digital therapeutics and want to know the latest analyses, trends, and tangible lessons, my latest guest on Alloutcoach, Giorgia Pezzotta is the person I strongly recommend that you follow. Giorgia is a health and innovation engineer, emerging leader, and entrepreneur recognized among 100 under 35 young …

1
Why Phage Therapy May Fail 37:32

3M ago37:32

37:32

Phage therapy has gained a lot of traction but the challenges created by this approach have not been properly assessed at a big scale. We often read about therapy successes on isolated cases but, rarely, we read or hear about failures. AAC recently published a case series of patients who failed phage therapy. Today, we will discuss this topic with …

1
WHY GOING TO WORK SHOULD BE LIKE COMPETING IN A SPORT 54:03

3M ago54:03

54:03

In this new "InWeekend" series premiere of the podcast, the host, Tim Mikhelashvili, CEO of Amedea Pharma shares real world lessons from his career in the Medical Affairs function in the pharmaceutical industry to propose a modern approach to raising new standards in healthcare quality and ways of working in an environment constrained by resources …

1
Martin Hoenigl on climate change and fungal diseases 35:18

3M ago35:18

35:18

Rebecca Barksby of The Lancet Microbe speaks with Professor Martin Hoenigl about the impact of climate change and natural disasters on fungal diseases. Read the full article: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(24)00039-9/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanmic Continue this conversation on social! Follow us…

1
Nancy Chow on sporotrichosis 21:25

4M ago21:25

21:25

Rebecca Barksby of The Lancet Microbe speaks to Dr Nancy Chow about sporotrichosis and discusses a genomic epidemiology study of this zoonotic fungal disease among people and cats in Brazil. Read the full article: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(23)00364-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanmic Continue…

1
DESIGNING THE HEALTHCARE DELIVERY OF OUR DREAMS WITH AI / ML TODAY 39:24

4M ago39:24

39:24

On this special Live broadcast of the @Alloutcoach Podcast I welcomed back Dr. Pierantonio Russo, Chief Medical Officer at EVERSANA, cardiac and heart transplant surgeon trained at Mayo Clinic, academic medical school lecturer, expert in health economics and population medicine, bioinformatics, Machine Learning, and digital medicine to the show to …

1
Is Lophomonas a Pathogen? 34:33

4M ago34:33

34:33

The protozoan Lophomonas has been reported to be a pathogen of humans in a large number of case reports and case series. Most of these case reports describe infections of the respiratory tract. Editors in Conversation is joined by two experts to discuss this possible parasite. Some of the questions addressed include: What are the characteristics of…

1
Deborah Williamson and Michael Moso on detecting on-SARS-CoV-2 viruses from COVID-19 rapid antigen test devices 19:01

5M ago19:01

19:01

Elena Dalla Vecchia of The Lancet Microbe speaks to Deborah Williamson and Michael Moso about non-SARS-CoV-2 respiratory viral detection from COVID-19 rapid antigen test devices. Read the full article: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(23)00375-0/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanmic Continue this conver…

1
Treatment of Multidrug-resistant Tuberculosis 40:17

5M ago40:17

40:17

Tuberculosis is one of the most deadly infectious diseases that still causes significant burden of disease, particularly in the developing world. The emergence of resistance to first line agents severely limits the therapeutic options and threaten the ability to control dissemination of this disease. Fortunately, new drugs and regimens are now emer…

1
INNOVATIONS IN TEACHING MEDICINE AND TESTING VIA PODCASTS 25:57

5M ago25:57

25:57

With rising socio-economic pressures on health systems and healthcare professionals to continue to deliver the best clinical outcomes, staff shortages and countless sources of Medical Information to support their approaches to patient care, the topic of practical methods of applying Medical Education in innovative ways has never been more critical.…

1
New generation B-lactam/B-lactamase inhibitors: Taniborbactam 47:47

6M ago47:47

47:47

A new generation of B-lactamase inhibitors is likely to reach the market in the upcoming year. These broad-spectrum inhibitors exhibit activity against the most feared class B metallo-B-lactamases maintaining the inhibition of other enzymes. Recently AAC has published three papers that describe the mechanistic bases of taniborbactam resistance amon…

1
CREATING A NEW HEALTH GENERATION WITH PREVENTION AND LONGEVITY MEDICINE 47:04

6M ago47:04

47:04

What a better way to start the new 2024 year than to learn about the current, realistic prospect of living longer and better lives due to the latest advances in medicine and pharmaceutical research from a preventive and longevity medicine advocate, researcher, and expert, James Peyer, PhD. This episode features a personal, candid story of his journ…

1
NEW RENAISSANCE IN HEALTHCARE - INNOVATION OLYMPICS SERIES EPISODE 1 15:10

6M ago15:10

15:10

I am excited to kick off a new series of episodes on the Alloutcoach Podcast called "Innovation Olympics" which will capture some of the most memorable messages and lessons from the Opening Ceremony of the global annual ideation competition in which innovators in healthcare become "Olympians" for about 16 days and exchange their inspiration with sp…

1
Favorite Clinical Microbiology Papers of 2023 (JCM ed.) 1:05:16

6M ago1:05:16

1:05:16

We managed to make it through 2023 without a major epidemic or pandemic, and as we get into the holiday spirit and look forward to the new year, some of us took a look back and picked out one of our favorite JCM paper published in 2023, which I will tell you, was no easy task as there were many of good ones to choose from! And personally, after loo…

1
Global Funding Opportunity at INCATE with Dr. Mercedes Gonzalez and Kinzbio CEO Dr. Gregorio Iraola 32:34

7M ago32:34

32:34

Welcome back to Phage Therapy Today! As phage therapy is becoming global, so are funding opportunities. In this week's episode, our guests, Dr. Mercedes Gonzalez from Incubator for Antibacterial Therapies in Europe (INCATE) and Dr. Gregorio Iraola, at Kinzbio sat down with us to talk about these funding opportunities and how startup companies can b…

1
Antimicrobial Resistance in Neisseria Gonorrhoeae (JCM ed.) 28:14

7M ago28:14

28:14

Gonorrhea remains one of the more common sexually transmitted infections. In North America, the number of reported cases has generally risen for over ten years, with interruptions in the early days of the COVID-19 pandemic, followed by returns to rising rates of infection. Under the selective pressure of antimicrobial treatment, antimicrobial resis…

1
Kate Baker on harnessing genomics for antimicrobial resistance surveillance 19:19

7M ago19:19

19:19

Rebecca Barksby of The Lancet Microbe speaks to Professor Kate Baker about the challenges, potential, and recommendations for using genomics to monitor antimicrobial resistance. Read the full Series: https://www.thelancet.com/series/amr-genomics?dgcid=buzzsprout_icw_podcast_generic_lanmic Continue this conversation on social! Follow us today at... …

1
New Antifungals (AAC ed.) 45:49

8M ago45:49

45:49

In the last few years we have witnessed the rise of very resistant fungal species some of them likely influenced by environmental conditions and climate change. Fortunately, there has been a bit of an explosion in the development of new antifungals and the pipeline has been strengthened in the last decade. We will have the ability to have new molec…

1
A Novel Coccidioides Antibody LFA (JCM ed.) 44:00

9M ago44:00

44:00

Despite the many advances in diagnostic testing for infectious diseases, detection of Coccidoides infections continues to rely on serologic assessment for anti-fungal antibodies, and what is perhaps more astonishing is that the serologic methods we use today, such as complement fixation and immunodiffusion, were first developed about a century ago.…

1
Phage Therapy: Current Prospects 13:10

9M ago13:10

13:10

In this episode, learn more about current applications of phage therapy, an alternative to antibiotics! We're here to give an update of bacteriophages (viruses that infect bacteria) and the current state of affairs in research and clinical applications. Listen in to learn a little about how bacteriophages are being modified to treat bacterial infec…

1
Climate Change and Antimicrobial Resistance (AAC ed.) 29:26

9M ago29:26

29:26

Climate change is possibly the major threat that planet earth is experiencing in this century with potential catastrophic consequences. As the planet warms, the change in weather patterns is affecting the microbial ecology in such a manner that humans are facing new health threats including emerging diseases and facing species of organisms that are…

1
Emerging Antifungal-Resistant Dermatophytes (JCM ed.) 29:26

10M ago29:26

29:26

Fungi that are resistant to antifungal drugs have been very much in the news and even the subject of the hugely popular television program, The Last of Us. We talk with two experts in mycology and fungal susceptibility testing about the recent descriptions of terbinafine-resistant dermatophytes in the United States. Some of the questions we will ad…

1
OLYMPIC JOURNEY OF BEATING ALL ODDS AND PUTTING PATIENTS ON THE PODIUM 48:50

10M ago48:50

48:50

Watch the latest @Alloutcoach podcast Live with Gary Hall, Jr., 5-time Olympic gold medalist, Keynote Speaker, Type 1 Diabetes Patient Advocate, Sanford Health Consultant, Board Member, and Humanitarian. This is a truly unforgettable, personal and intriguing discussion that breaks down Gary's resilience, philosophy of competition, and transformatio…

1
Artificial Intelligence and Infectious Diseases (AAC ed.) 38:55

10M ago38:55

38:55

Artificial intelligence (AI) has the potential to change the way we practice medicine and public health. The tools and AI approaches can substantially impact a broad range of fields from the manner we approach patient care to strategies to discover new antimicrobials, track pandemics and deploy public health measures. AAC recently published a comme…

1
POWER OF DATA ANALYTICS TO IMPROVE AND PERSONALIZE OUR HEALTH 39:33

10M ago39:33

39:33

In the latest episode of the Alloutcoach Podcast I spoke with Dr. Pierantonio Russo, (Corporate Chief Medical Officer @Eversana), a cardiac and heart transplant surgeon, former Chief of Cardiac Surgery and Pediatric Cardiac Surgery at a various top academic hospitals across the U.S. with expertise in machine learning, data analytics, health economi…

Podcasts Worth a Listen

Phage Therapy Podcasts

Podcasts Worth a Listen

Quick Reference Guide